DE69824206D1 - Menschliches "minor vault" protein p193 - Google Patents

Menschliches "minor vault" protein p193

Info

Publication number
DE69824206D1
DE69824206D1 DE69824206T DE69824206T DE69824206D1 DE 69824206 D1 DE69824206 D1 DE 69824206D1 DE 69824206 T DE69824206 T DE 69824206T DE 69824206 T DE69824206 T DE 69824206T DE 69824206 D1 DE69824206 D1 DE 69824206D1
Authority
DE
Germany
Prior art keywords
protein
minor vault
human
vault protein
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69824206T
Other languages
English (en)
Inventor
H Rome
A Kickhoefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE69824206D1 publication Critical patent/DE69824206D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
DE69824206T 1998-06-03 1998-06-03 Menschliches "minor vault" protein p193 Expired - Fee Related DE69824206D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/011348 WO1999062547A1 (en) 1998-06-03 1998-06-03 HUMAN MINOR VAULT PROTEIN p193

Publications (1)

Publication Number Publication Date
DE69824206D1 true DE69824206D1 (de) 2004-07-01

Family

ID=22267215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824206T Expired - Fee Related DE69824206D1 (de) 1998-06-03 1998-06-03 Menschliches "minor vault" protein p193

Country Status (7)

Country Link
EP (1) EP1083927B1 (de)
JP (1) JP2002516675A (de)
AT (1) ATE267611T1 (de)
AU (1) AU762371B2 (de)
CA (1) CA2330833A1 (de)
DE (1) DE69824206D1 (de)
WO (1) WO1999062547A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003232200A1 (en) * 2002-04-08 2003-10-20 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases
US8124109B2 (en) 2008-05-15 2012-02-28 The Regents Of The University Of California Vault compositions for immunization against chlamydia genital infection
CA2779512C (en) 2009-11-02 2017-01-17 Leonard H. Rome Vault complexes for cytokine delivery
US8551781B2 (en) 2009-11-19 2013-10-08 The Regents Of The University Of California Vault complexes for facilitating biomolecule delivery
CN104797709A (zh) * 2012-11-19 2015-07-22 国立研究开发法人科学技术振兴机构 人工生物粒子及其制造方法
CN112724253B (zh) * 2021-03-09 2022-04-05 生工生物工程（上海）股份有限公司 抗人穹窿体蛋白的抗体及其应用

Also Published As

Publication number Publication date
WO1999062547A1 (en) 1999-12-09
EP1083927A1 (de) 2001-03-21
JP2002516675A (ja) 2002-06-11
CA2330833A1 (en) 1999-12-09
EP1083927A4 (de) 2002-01-02
EP1083927B1 (de) 2004-05-26
AU7810398A (en) 1999-12-20
AU762371B2 (en) 2003-06-26
ATE267611T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
BR9506820A (pt) Derivados de 4-amino de ácido micofenólico
DE60043197D1 (de)
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
PT915697E (pt) Anticonvulsionantes derivados do sulfamato uteis no tratamento da obesidade
PH31406A (en) 6-Substituted mycophenolic acid and derivatives.
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
IS5852A (is) Lyfjamiðlar til meðhöndlunar á parkinsonsveiki ADHD og smákirtilsæxlum
DE69709003D1 (de) Herstellung von Bisphenol-A
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE69824206D1 (de) Menschliches "minor vault" protein p193
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE60239670D1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
NO307166B1 (no) Forbedringer vedroerende pasientheiser
AU9334098A (en) Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
RU95114858A (ru) Новый пептидный фрагмент, обладающий биологической активностью инсулина
KR970023499U (ko) 생물학적 순산소 개방형 폐수 처리장치
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee